S100A9-Induced Overexpression of Pd-1/Pd-L1 Contributes to Ineffective Hematopoiesis In Myelodysplastic Syndromes
D-1/PD-L1 blockade therapy, alone or in combination with other strategies, may have therapeutic potential to restore and promote effective hematopoiesis in MDS, according to new research from Moffitt Cancer Center that was published in Nature.com.
News
- Bacteriotherapy Heals Cisplatin Damage
- ER Stress Thwarts Protective Anti-Tumor Immunity Through T-bet Repression
- Fighting Cancer with Mathematics and Viruses
- ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center
- Moffitt Researchers Characterize Mechanism of Action of CAR T Cells
- Moffitt Researchers Identify Novel Target to Improve Chemotherapeutic Response in Breast Cancer
- NHLBI selects Moffitt Cancer Center as one of the Cell Therapies Processing Facilities
- S100A9-Induced Overexpression of Pd-1/Pd-L1 Contributes to Ineffective Hematopoiesis In MDS